eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.72+0.20 (+3.62%)

Delayed quote: Oct 6, 2026, 10:42 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T14:51:58.002Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:51:58.002Z.

Quote observation: 2026-10-06T14:42:29.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 5.72
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.2

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

EXOZ PE Ratio Metrics

PE RATIO

N/A

EXOZ Competitors' PE Ratio

EXOZ

eXoZymes, Inc.

Current

Market Cap

$53.09M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs EXOZ

Market Cap

$53.69M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$53.81M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$51.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$51.33M

PE Ratio

N/A

TTM Avg

135.17

3Y Avg

135.17

5Y Avg

135.17

MDAI

Spectral AI, Inc.

vs EXOZ

Market Cap

$54.90M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs EXOZ

Market Cap

$51.16M

PE Ratio

9.94

TTM Avg

4.82

3Y Avg

27.98

5Y Avg

18.54

NMAD

NOMAD Power Solutions, Inc.

vs EXOZ

Market Cap

$50.92M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs EXOZ

Market Cap

$50.25M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs EXOZ

Market Cap

$49.85M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$53.09M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$53.69M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$53.81M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.44M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	135.17	135.17	135.17
Spectral AI, Inc. (MDAI)vs ›	$54.90M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.16M	9.94	4.82	27.98	18.54
NOMAD Power Solutions, Inc. (NMAD)vs ›	$50.92M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$50.25M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$49.85M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$5.72

Forward EPS (Est.)

$-1.19

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

EXOZ PE Ratio Metrics

EXOZ Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics